Cannae (CNNE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for December 12, 2025, with virtual participation and pre-registration required.
Board recommends voting for four incumbent director nominees, approval of executive compensation, ratification of Grant Thornton as auditor, declassification of the board, and against a shareholder proposal to engage an investment banker.
Proxy contest with Carronade Capital Management, which has nominated four alternative directors; board urges use of the universal WHITE proxy card for voting.
Significant capital returned to shareholders through repurchases and dividends, portfolio rebalancing, and new investments in private companies.
Transitioned from external to internal management, reducing costs and aligning incentives.
Voting matters and shareholder proposals
Proposal 1: Elect four Class II directors for three-year terms; board recommends Erika Meinhardt, Barry B. Moullet, James B. Stallings, Jr., and Frank P. Willey.
Proposal 2: Advisory vote to approve 2024 executive compensation (Say-on-Pay); board recommends approval.
Proposal 3: Ratify Grant Thornton LLP as independent auditor for 2025; board recommends approval.
Proposal 4: Amend and restate articles to declassify the board, moving to annual director elections by 2028; board recommends approval.
Proposal 5: Shareholder proposal to engage an investment banker; board recommends voting against.
Board of directors and corporate governance
Board has 12 members, 10 of whom are independent; recent refreshment added three independent directors since 2024.
Board leadership separated between Chairman, Vice Chairman, and Lead Independent Director.
Committees: Audit, Compensation, Corporate Governance and Nominating, and Related Person Transaction, all fully independent.
Board declassification proposed for phased implementation starting 2026.
Robust stock ownership guidelines and ongoing shareholder engagement.
Latest events from Cannae
- $630M D&B sale, $323M buybacks, and sports focus marked 2025; earnings call set for Feb 23, 2026.CNNE
Q4 202523 Feb 2026 - Q2 net loss of $155M, $222M+ returned to shareholders, and major portfolio realignment.CNNE
Q2 20242 Feb 2026 - Q3 net loss narrowed to $13.6M, NAV is $2.1B, and shares trade at a 37% discount.CNNE
Q3 202414 Jan 2026 - Q4 revenue fell 8% year-over-year, but portfolio growth and capital returns remain strong.CNNE
Q4 202423 Dec 2025 - Strategic investments and leadership in football assets drive growth; shareholders urged to vote.CNNE
Proxy Filing8 Dec 2025 - Shareholders are urged to back the Board’s nominees amid ongoing strategic transformation and governance reforms.CNNE
Proxy Filing2 Dec 2025 - Board recommends voting for nominees with proven expertise to ensure long-term value creation.CNNE
Proxy Filing1 Dec 2025 - Affirmed long-term value strategy, capital returns, and board alignment with shareholders.CNNE
Proxy Filing1 Dec 2025 - Strategic plan advances with DNB sale, major buybacks, and focus on private investments.CNNE
Proxy Filing1 Dec 2025